🧬 A Dynamic Bioprinting Hydrogel Made From…Crabs?
Chitosan-Based Biomaterials for 3D Bioprinting, Tissue Regeneration, and Drug Delivery This month, we sat down…
3D Bone and Cartilage Models to Understand Tissue Regeneration
This month, we sat down with Dr. Johanna Bolander. Dr. Bolander has a PhD in…
Ultra-Miniaturized Primary Hepatocyte Spheroids for Early-Stage Drug DiscoveryÂ
This month, we sat down with Dr. Brinton Seashore-Ludlow. Dr. Seashore-Ludlow has a PhD in…
3D Models of the Most Communicative Organ in the Body: Fat
This month, we sat down with Dr. Elvira Weber, adipose tissue organoid pioneer, expert in…
The Key to Moving 3D Culture Forward
This month, we sat down with Dr. Maryna Panamarova, a technical expert in the 3D…
A vision for animal-free drug testing with Dr. Tamara Zietek
This month, we sat down with Dr. Tamara Zietek, a pioneer in 3D intestinal modelling…
The need for standardization in 3D cell culture (let’s start small)
In the realm of 3D cell culture, the diversity of terminology – from organoids and…
5 benefits that 3D cell culture will bring to pharmaceutical drug development
Advances in 3D cell culture excite us — that’s why we got into this game.…
Lucero unveils new brand
Lucero unveils rebrand as they enter next stage of development.
Lucero awarded €1.3M Transition Grant by European Innovation Council
Lucero will ring in the new year with generous funding from the European Innovation Council…
Lucero awarded Vinnova Innovative Startups Stage 2 grant
Lucero awarded 900 000 SEK Vinnova Innovative Startups Stage 2 grant to build on Stage…
Tech Update: Promising local heating data during and post-irradiation using optical tweezers
Preliminary data showed a temperature increase of less than 1 degree C in HepG2 cells…
Lucero granted international project to advance microfluidic technology
Lucero has been granted a project by the European initiative, MedPhab, to accelerate the development…
Lucero moves to AstraZeneca’s BioVentureHub
Lucero has moved its offices to AstraZeneca’s BioVentureHub in Mölndal, Sweden.
Tinde Höjer joins Lucero team
Tinde Höjer joins the Lucero team to focus on microfluidic development and 3D cell culture…
Tech Update: Identifying miniature liver spheroids using Lucero AI
We are happy to share our latest results on spheroid detection and classification using our…
Lucero joins Nanoscale Drug Testing consortium
The consortium aims to develop a “near-patient drug development” strategy that includes using 3D cell…
Lucero awarded Vinnova Innovative Startups Stage 1 grant
Out of 934 applicants, Lucero was selected by Vinnova, Sweden’s Innovation Agency, as one of…
Lucero to participate in SPIE Startup Challenge semi-finals 2021
Lucero has been selected by SPIE, the international society for optics and photonics, as one…
Lucero initiates project with ACTPHAST4.0
With the help of ACTPHAST4.0 partners, VUB B-PHOT Brussels Photonics and Vrije Universiteit Brussel, both…
Lucero co-founder, Dr. Falko Schmidt, completes Ph.D. in natural science
We are proud to announce that Lucero’s co-founder, Falko Schmidt, has successfully defended his Ph.D.…
Lucero wins 50 000 SEK Chalmers Ventures’ Accelerator Pitch 2020
Chalmers Ventures hosted their annual Accelerator Pitch event during the first week of November. The…
Lucero voted “Best HealthTech Startup in Sweden”
The Lucero team would like to extend our warmest thanks to the Nordic Startup Awards…
Lucero selected to pitch at EIT Pitch Day Finals
At the end of each of EIT’s programs, two participating companies are chosen to pitch…
Chalmers Ventures Accelerator Pitch Day 2020
Pitch Day 2020 (or week, rather) is underway! Seven promising startups from Chalmers Ventures’ Accelerator…
Lucero included in “Best AI Startups in Sweden” by AI Sweden, Ignite Sweden and RISE
Lucero is pleased to announce that it has been included in this year’s AI Landscape…
Lucero Selected as one of ten finalists for EIT Health Validation Lab Pitch Day
Lucero has been participating in the EIT Health Validation during the past eight weeks. The…
Lucero participates in InfoShare quarter-finals
Lucero will participate in the quarter-finals of the InfoShare Startup Contest today for a chance…
Lucero co-founder, Falko Schmidt, announced as a speaker at International Digital Healthtech, Healthcare & Pharmacy Conference
We are proud to share that our Lucero’s co-founder, Falko Schmidt, has been chosen to…
Lucero receives 50,000 SEK verification grant from Almi Företagspartner Väst
Lucero has been awarded Almi Företagspartner Väst’s verification grant to help fund prototype development that…
Lucero joins Chalmers Ventures’ top Accelerator program
Lucero has joined the Gothenburg-based Chalmers Ventures’ Accelerator program. The Accelerator has been supporting great…
Lucero accepted to Cohort 1 – HealthTech, BioTech, & MedTech, of X-Europe program
Lucero will participate in the X-Europe program this fall to further develop our product-market fit…
Lucero selected to participate in Venture Cup’s Startup 2020 Western Regional finals in Gothenburg
“It’s an honor to be competing in the most prestigious startup competition in Sweden. There…
Lucero awarded €150,000 ERC Proof of Concept grant to begin prototype development
We are very honored and happy to share that from the hands of our great…
Lucero selected to participate in Fifty Founders Battle semi-finals at Techchill, Riga
Lucero will compete in the MedTech vertical of the Fifty Founders Battle pitch competition alongside…
Lucero selected to participate in SPIE Startup Challenge semi-finals at SPIE Photonics West in San Francisco
Lucero has been selected by SPIE, the international society for optics and photonics, as one…
Lucero ranked as one of the Top 20 business ideas in Sweden by Venture Cup Sweden
A big congratulations to the other winners from the west of Sweden: ZoundWave, Aquammodate, Spacerpad,…
